Dariet R 600 Tablets (Darunavir 600 mg + Ritonavir 100 mg)
Dariet R 600 Tablets contain Darunavir 600 mg and Ritonavir 100 mg, a combination of protease inhibitor medicines used as part of combination antiretroviral therapy (ART) for the treatment of HIV-1 infection. Darunavir suppresses HIV replication, while Ritonavir boosts Darunavir blood levels by slowing its metabolism, helping maintain effective therapeutic concentrations. This combination is widely recommended in appropriate ART regimens under specialist supervision.
Manufactured and exported by Cordium Pharmaceuticals Pvt. Ltd., Dariet R 600 Tablets are supplied to pharmaceutical distributors, government tenders, hospitals, NGOs, and importers across multiple international markets.
Mechanism of Action (MOA) of Dariet R 600 Tablets
Darunavir 600 mg
Darunavir is an HIV-1 protease inhibitor. It blocks the viral protease enzyme responsible for processing viral polyproteins into mature viral proteins. As a result:
HIV cannot produce mature infectious virus particles.
Viral replication is significantly reduced.
The immune system is better able to recover and function.
Ritonavir 100 mg
Ritonavir is primarily used as a pharmacokinetic booster. It inhibits the CYP3A enzyme that metabolizes Darunavir, leading to:
Increased Darunavir plasma concentrations
Longer duration of action
Improved antiviral effectiveness
Reduced dosing variability
This boosting effect substantially increases Darunavir exposure compared with Darunavir alone.
Uses of Dariet R 600 Tablets
Dariet R 600 Tablets are indicated for:
HIV-1 infection treatment in adults
Treatment-experienced HIV patients
Combination antiretroviral therapy (ART)
Viral load suppression
Improving CD4 cell count
Reducing progression toward AIDS
Long-term HIV disease management
Important: Dariet R 600 Tablets are not a cure for HIV and should always be used as part of a complete ART regimen prescribed by an experienced healthcare provider.
Key Benefits
High antiviral activity
Proven protease inhibitor therapy
Ritonavir-boosted efficacy
Reduced HIV viral load
Improved immune response
Suitable for many treatment-experienced patients
Manufactured under stringent quality standards
Export-quality packaging
Common Side Effects
Some patients may experience:
Nausea
Diarrhea
Headache
Rash
Vomiting
Fatigue
Abdominal discomfort
Patients should take the medicine exactly as prescribed and report persistent or severe adverse effects to their healthcare provider.
Global Export Markets
Cordium Pharmaceuticals Pvt. Ltd. supplies Dariet R 600 Tablets to pharmaceutical importers, hospitals, NGOs, and healthcare distributors in:
🇰🇪 Kenya
🇳🇬 Nigeria
🇬🇭 Ghana
🇵🇭 Philippines
🇻🇳 Vietnam
🇦🇪 UAE
🇸🇦 Saudi Arabia
🇺🇿 Uzbekistan
🇰🇿 Kazakhstan
🇺🇸 USA
🇬🇧 UK
🇿🇦 South Africa
Why Choose Cordium Pharmaceuticals Pvt. Ltd.?
Cordium Pharmaceuticals is a trusted Indian pharmaceutical exporter offering:
WHO-GMP manufacturing standards
Export-quality packaging
Competitive wholesale pricing
Reliable international logistics
Bulk supply capability
Custom labeling (where applicable)
Regulatory documentation support
Fast global shipment
The company supplies antiretroviral medicines to international distributors and healthcare organizations.
Frequently Asked Questions (FAQs)
Is Dariet R 600 used to cure HIV?
No. It controls HIV replication but does not eliminate the virus. It must be used as part of combination ART.
Why is Ritonavir included?
Ritonavir boosts Darunavir levels by slowing its metabolism, improving treatment effectiveness.
Can Dariet R 600 be taken alone?
No. It should be used only with other antiretroviral medicines as directed by an HIV specialist.
